Back

Prognostic value of the right coronary venous anatomy in patients undergoing cardiac resynchronization therapy

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Miscellaneous clinical studies in heart failure (4) Imaging ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Madalina Patricia Moldovan

Heart Institute Nicolae Stancioiu, Cluj Napoca (Romania)

7 More presentations in this session

Presentation thumbnail
Albuminuria is associated with progression of diastolic dysfunction in patients at risk for cardiovascular disease
Doctor K. Min (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Continuous monitoring of heart failure biomarker using a sensitive graphene-based electrical sensor
Mr A. Gilani (CH) Miss L. De Schrijver (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Selenium, selenoprotein P and autoantibodies to selenium transport proteins in Swedish heart failure patients - a pilot study in preparation for a randomized supplementation trial
Doctor J. Molvin (Malmoe, SE)
Abstract Slides Video
Presentation thumbnail
Residual congestion in acute decompensated heart failure: A novel approach through microvascular imaging of renal circulation
Doctor K. Kayama (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Anemia and 4 cavities myocardial strain in acute heart failure
Doctor L. Soulat-Dufour (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous clinical studies in heart failure (4)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impact of right ventricular dimension and function on outcomes in patients undergoing cardiac resynchronization therapy
thumbnail
Congress Presentation
Bio-humoral and haemodynamic correlates of renal venous congestion across the heart failure spectrum
thumbnail
Congress Presentation
Right ventricular systolic pressure is an independent risk factor of all-cause death and inappropriate therapies in patients with implanted CRT-D

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources